Abstract: In order to provide a method with which the costs incurred in conventional methods for producing chlorine dioxide according to the chlorite-acid method can be significantly lowered, a method is proposed according to the invention, in which an acid, a chlorite and optionally water are introduced into a reactor, wherein in the method the reaction temperature in the reactor is determined and the quantity of acid, chlorite and/or water which is/are introduced into the reactor is chosen such that the acid introduced into the reactor is introduced into the reactor with a molar excess relative to the chlorite introduced into the reactor, wherein the level of the molar excess is varied with the level of the reaction temperature determined. In addition, the present invention relates to a device which is suitable for implementing the method according to the invention.

Abstract: The invention relates to the use of copolycarbonates stable at high temperature as a supporting material in the FDM (fused deposition modeling) method, said copolycarbonates having a Vicat temperature determined in accordance with ISO 306:2013 of at least 150° C. Polyester, polyamide, PC/polyester blend, and/or polyaryl ether ketone is used as a printing material.

Abstract: The present invention relates to polycarbonate compositions for producing halogen-free moulded parts for use in public facilities which meet the corresponding fire protection regulations and standards. The present invention also relates to the use of halogen-free polycarbonate compositions for producing moulded parts, particularly seating and/or parts of seating, e.g. seat shells, which are flame-retardant and meet the standards for use in public buildings, as well as the moulded parts themselves.

Abstract: The present invention relates to complexes which contain magnetic iron oxide particles in a pharmaceutically acceptable shell, said particles having a diameter of 20 nm to 1 ?m with an overall particle diameter/core diameter ratio of less than 6, and to the use of these complexes in magnetic particle imaging (MPI). Particular preference is given to the use of these compositions in examining the gastrointestinal tract, the vascular system of the heart and cranial components, in the diagnosis of arteriosclerosis, infarctions, and tumors and metastases, for example of the lymphatic system.

Abstract: The present invention relates to complexes which contain polycrystalline magnetic iron oxide particles in a pharmaceutically acceptable shell, and to the use of these compositions in magnetic particle imaging (MPI). Particular preference is given to the use of these compositions in examining the gastrointestinal tract, the vascular system of the heart and cranial components, in the diagnosis of arteriosclerosis, infarctions, and tumors and metastases, for example of the lymphatic system.

Abstract: The invention relates to a process for the production of gaseous microparticles for ultrasonic diagnosis, whose wall material is built up from polyesters of &agr;-, &bgr;- or &ggr;- hydroxycarboxylic acids, particles that are produced according to this process, as well as their use in medical diagnosis.

Abstract: The invention relates to gaseous microparticles for ultrasonic diagnosis, whose wall material is built up from block copolymers of polyesters of &agr;-, &bgr;- or &ggr;-hydroxycarboxylic acids with linear or star-shaped polyethylene glycols and optionally liquid crystals or whose wall material is built up from polyesters of &agr;-, &bgr;- or &ggr;-hydroxycarboxylic acids and liquid crystals, media that contain these particles for ultrasonic diagnosis, as well as a process for the production of the media and particles.

Abstract: Microparticles comprising biodegradable polymers, characterized in that they are synthesized from polymerizable aldehydes, which optionally contain additives and/or crosslinkers capable of copolymerization, optionally surfactants or surfactant mixtures, gases and/or highly volatile liquids in free or bound form, coupling agents, optionally biomolecules or macromolecules bound by these coupling agents as well as optionally diagnostically or therapeutically effective components, are suitable as ultrasonic contrast media.